X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1540) 1540
Newspaper Article (1055) 1055
Publication (168) 168
Newsletter (43) 43
Book Chapter (20) 20
Book / eBook (17) 17
Book Review (13) 13
Magazine Article (5) 5
Dissertation (4) 4
Conference Proceeding (3) 3
Trade Publication Article (3) 3
Report (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
polypeptides (1989) 1989
proteins (1019) 1019
vaccines (787) 787
index medicus (750) 750
animals (742) 742
inventors (712) 712
patents (667) 667
antigens (611) 611
humans (577) 577
amino acids (420) 420
immunology (392) 392
viruses (383) 383
infections (352) 352
mice (329) 329
virology (242) 242
immunoglobulins (238) 238
cancer (223) 223
microbiology (221) 221
female (215) 215
research article (212) 212
immunization (210) 210
peptides (209) 209
amino acid sequence (203) 203
molecular sequence data (200) 200
genomes (199) 199
medicine (197) 197
methods (193) 193
lymphocytes (192) 192
health aspects (189) 189
biochemistry & molecular biology (186) 186
research (186) 186
deoxyribonucleic acid--dna (184) 184
gene expression (181) 181
antibodies (179) 179
science (179) 179
analysis (173) 173
infectious diseases (172) 172
multidisciplinary sciences (156) 156
medicine, research & experimental (155) 155
male (151) 151
vaccination (148) 148
biology (146) 146
immune system (146) 146
pharmaceuticals (146) 146
medical research (143) 143
biotechnology & applied microbiology (139) 139
enzyme-linked immunosorbent assay (139) 139
immunotherapy (139) 139
vaccine (138) 138
infection (135) 135
polypeptide (135) 135
e coli (133) 133
immune response (131) 131
hepatitis (130) 130
bacteria (129) 129
expression (129) 129
mutation (126) 126
identification (124) 124
mice, inbred balb c (122) 122
enzymes (120) 120
immunogenicity (117) 117
cytokines (112) 112
pharmaceutical industry (110) 110
influenza (109) 109
life sciences (109) 109
genes (107) 107
biochemistry (106) 106
protein (104) 104
biotechnology (103) 103
immunity (103) 103
virus diseases (101) 101
cloning (99) 99
genetic aspects (99) 99
tumors (99) 99
dna (98) 98
article (97) 97
recombinant (93) 93
disease (92) 92
cells (90) 90
dendritic cells (90) 90
physiological aspects (89) 89
stock exchanges (89) 89
cell line (87) 87
cytotoxicity (87) 87
pathogens (87) 87
glycoproteins (86) 86
epitopes (85) 85
genetic engineering (85) 85
ligands (85) 85
protein binding (85) 85
studies (85) 85
viral infections (84) 84
antigenic determinants (83) 83
escherichia-coli (83) 83
parasitology (83) 83
cancer therapies (82) 82
market positioning (82) 82
cell biology (81) 81
veterinary sciences (80) 80
human immunodeficiency virus--hiv (79) 79
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Online Resources - Online (2) 2
UTL at Downsview - May be requested (2) 2
UofT at Mississauga - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2679) 2679
Japanese (8) 8
Chinese (4) 4
Russian (2) 2
Spanish (2) 2
French (1) 1
German (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Archives of Virology, ISSN 0304-8608, 6/2019, Volume 164, Issue 6, pp. 1501 - 1513
Journal Article
Vaccine, ISSN 0264-410X, 06/2018, Volume 36, Issue 26, pp. 3740 - 3746
•We developed novel DNA and viral vector based vaccines comprising the S, PreS1, and Core antigens of HBV.•This study first explored the immune responses of... 
Antigen | Rhesus macaques | Vaccine | Therapeutic application | Hepatitis B virus | Immunity | MEDICINE, RESEARCH & EXPERIMENTAL | THERAPEUTIC VACCINE | TOLERANCE | HBSAG | IMMUNOLOGY | DAMAGE | IMMUNOGENICITY | ROBUST | INFECTION | HBCAG | MICE | PROTEINS | Antigens, Viral - administration & dosage | Hepatitis B Vaccines - administration & dosage | Vaccines, DNA - immunology | Hepatitis B Surface Antigens - immunology | Male | Macaca mulatta | Vaccines, Subunit - immunology | Vaccines, Synthetic - immunology | Vaccines, DNA - administration & dosage | Hepatitis B Core Antigens - immunology | Hepatitis B Surface Antigens - administration & dosage | Antigens, Viral - immunology | Animals | Immunity, Humoral | Time Factors | Vaccines, Subunit - administration & dosage | Female | Immunization Schedule | Hepatitis B Vaccines - immunology | Vaccines, Synthetic - administration & dosage | Hepatitis B virus - immunology | Immunity, Cellular | Longitudinal Studies | Hepatitis B Core Antigens - administration & dosage | Antigens | Medical research | Immune response | Analysis | Vaccination | Medicine, Experimental | Vaccines | Health aspects | Hepatitis B | Candidates | Model testing | Liver | Clinical trials | Cytotoxicity | Viruses | Infections | DNA vaccines | Immunity (cell-mediated) | Proteins | Hepatitis | Lymphocytes | Conflicts of interest | Immunity (humoral) | Deoxyribonucleic acid--DNA | Recombinant | Immune system | Polypeptides | Therapeutic applications | Immune response (cell-mediated) | T cell receptors | Correlation analysis | Adenoviruses | Laboratory animals
Journal Article
PloS one, ISSN 1932-6203, 2019, Volume 14, Issue 9, p. e0222148
Journal Article
Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 04/2014, Volume 10, Issue 4, pp. 887 - 895
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2011, Volume 6, Issue 9, p. e24413
Background: In a previous Phase 1/2b malaria vaccine trial testing the 3D7 isoform of the malaria vaccine candidate Merozoite surface protein 2 (MSP2),... 
MEROZOITE SURFACE PROTEIN-2 | IMMUNOGENICITY | HUMORAL RESPONSE | CLINICAL MALARIA | MULTIDISCIPLINARY SCIENCES | ANCHORED MEMBRANE-PROTEINS | IN-VITRO GROWTH | INHIBITORY ANTIBODIES | ENDEMIC AREA | PLASMODIUM-FALCIPARUM MALARIA | PAPUA-NEW-GUINEA | Protozoan Proteins - adverse effects | Antigens, Protozoan - immunology | Dose-Response Relationship, Immunologic | Immunity, Humoral - immunology | Humans | Plasmodium falciparum - immunology | Life Cycle Stages - immunology | Malaria Vaccines - chemistry | Young Adult | Protein Isoforms - chemistry | Malaria Vaccines - adverse effects | Malaria Vaccines - immunology | Antibodies - immunology | Adult | Protozoan Proteins - chemistry | Antigens, Protozoan - adverse effects | Antigens, Protozoan - chemistry | Protein Isoforms - adverse effects | Chemistry, Pharmaceutical | Mannitol - analogs & derivatives | Immunity, Cellular - immunology | Animals | Adolescent | Mannitol - chemistry | Plasmodium falciparum - growth & development | Protein Isoforms - immunology | Oleic Acids - chemistry | Protozoan Proteins - immunology | Cohort Studies | Malaria | Malaria vaccine | Immunoglobulin G | Vaccination | Clinical trials | Product development | Vaccines | Enzyme-linked immunosorbent assay | Erythrocytes | Antibodies | Infections | Biochemistry | Parasites | Merozoite surface protein 2 | Western blotting | Proteins | Technology transfer | Children | Recombinant | Vector-borne diseases | Medical research | Antigens | Immunization | Immunoglobulins | Polypeptides | Melanoma | Microscopy | Collaboration | Isoforms | Adults | Immunofluorescence
Journal Article
The Journal of Immunology, ISSN 0022-1767, 03/2004, Volume 172, Issue 5, pp. 3094 - 3100
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 30, Issue 12, pp. 2125 - 2130
Highlights ► HBc-5EPIS was made by inserting 5 mimotope of IBDV VP2 into MIR of HBc. ► HBc-5EPIS was efficiently expressed by E. coli and formed VLP. ►... 
Allergy and Immunology | Mimotope vaccine | Hepatitis B virus core particle | Virus-like particle | Chimeric VLP | Infectious bursal disease virus | MEDICINE, RESEARCH & EXPERIMENTAL | RECOMBINANT VP2 VACCINE | PREVENTION | IMMUNOLOGY | DISPLAY | DNA VACCINE | GENE | SURFACE | ANTIBODY-RESPONSES | CPG OLIGODEOXYNUCLEOTIDE | ANTIGEN | EPITOPES | Viral Vaccines - genetics | Hepatitis B Core Antigens - metabolism | Neutralization Tests | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Epitopes - immunology | Vaccination - methods | Vaccines, Virosome - immunology | Infectious bursal disease virus - immunology | Gene Expression | Birnaviridae Infections - prevention & control | Enzyme-Linked Immunosorbent Assay | Vaccines, Virosome - administration & dosage | Vaccines, Synthetic - genetics | Recombinant Proteins - genetics | Injections, Intramuscular | Epitopes - genetics | Vaccines, Virosome - genetics | Hepatitis B Core Antigens - genetics | Viral Vaccines - administration & dosage | Animals | Escherichia coli - genetics | Chickens | Poultry Diseases - prevention & control | Poultry Diseases - immunology | Infectious bursal disease virus - genetics | Birnaviridae Infections - immunology | Vaccines, Synthetic - administration & dosage | Viral Vaccines - immunology | Antibodies, Neutralizing - blood | Viral antibodies | Virus diseases | Antibodies | Hepatitis B virus | Hepatitis B | Antigenic determinants | Proteins | Polypeptides | Disease | E coli | Plasmids | Poultry | Herpes viruses | Vaccines | Antigen presentation | Core protein | Adjuvants | Data processing | Epitopes | Immunity | Survival | Enzyme-linked immunosorbent assay | Virus-like particles
Journal Article
Nature Medicine, ISSN 1078-8956, 08/2012, Volume 18, Issue 8, pp. 1254 - 1261
IMA901 is the first therapeutic vaccine for renal cell cancer (RCC) consisting of multiple tumor-associated peptides (TUMAPs) confirmed to be naturally... 
MEDICINE, RESEARCH & EXPERIMENTAL | COLONY-STIMULATING FACTOR | DENDRITIC CELLS | HIGH-FREQUENCIES | BIOCHEMISTRY & MOLECULAR BIOLOGY | MELANOMA PATIENTS | IDENTIFICATION | TUMOR-ANTIGEN | CUTTING EDGE | CELL BIOLOGY | MYELOID SUPPRESSOR-CELLS | REGULATORY T-CELLS | PEPTIDE VACCINE | Predictive Value of Tests | Cyclophosphamide - administration & dosage | Prognosis | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Kidney Neoplasms - immunology | Immunotherapy, Active | Male | Lymphocyte Depletion | Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use | Carcinoma, Renal Cell - immunology | Cyclophosphamide - therapeutic use | Kidney Neoplasms - blood | T-Lymphocytes, Regulatory - immunology | Cancer Vaccines - therapeutic use | Vaccines, Subunit - therapeutic use | Female | Carcinoma, Renal Cell - drug therapy | Immunosuppressive Agents - pharmacology | Chemokine CCL17 - blood | Immunosuppressive Agents - administration & dosage | Kidney Neoplasms - therapy | Carcinoma, Renal Cell - blood | HLA-A2 Antigen - immunology | Antigens, Neoplasm - immunology | Kaplan-Meier Estimate | Treatment Outcome | Combined Modality Therapy | T-Lymphocytes, Regulatory - drug effects | Cyclophosphamide - pharmacology | Biomarkers | Carcinoma, Renal Cell - therapy | CD8-Positive T-Lymphocytes - immunology | Kidney Neoplasms - drug therapy | Apolipoprotein A-I - blood | Cancer vaccines | Cyclophosphamide | Polypeptides | Immune response | Dosage and administration | Research | Health aspects | Kidney diseases | Peptides | Gene expression | Medical prognosis | Cancer | Immune system
Journal Article